Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transfer for Diabetes Control Post-Bariatric Surgery
NCT06192693Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2024
- Primary completion
- Feb 2029
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic fecal microbiota in type 2 diabetes mellitus (T2DM), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2024; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06192693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06192693.